Basics Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system. IPO Date: November 19, 2015 Sector: Healthcare Industry: Biotech Market Cap: $5.12B Activated in VL: True Average Daily Range Avg Daily Range: $1.13 | 3.00% Avg Daily Range (30 D): $1.50 | 1.39% Avg Daily Range (90 D): $2.09 | 1.85% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .48M Avg Daily Volume (90 D): .7M Trade Size Avg Trade Size (Sh.): 79 Avg Trade Size (Sh.) (30 D): 39 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 3,205 Avg Inst. Trade: $2.85M Avg Inst. Trade (30 D): $5.97M Avg Inst. Trade (90 D): $5.81M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.53M Avg Closing Trade (30 D): $7.8M Avg Closing Trade (90 D): $8.85M Avg Closing Volume: 52.93K         News May 29, 2025 @ 11:00 AM Axsome Therapeutics to Participate in Upcoming Inv... Source: N/A May 27, 2025 @ 7:44 PM Why Is Teva Stock Trading Higher On Tuesday? Source: Vandana Singh May 14, 2025 @ 11:30 PM Is Axsome Therapeutics Stock Worth the Risk? A Com... Source: The Motley Fool May 14, 2025 @ 10:30 PM Investor Alert: Class Action Lawsuits Against Gene... Source: Johnson Fistel, Pllp May 12, 2025 @ 11:08 AM Prediction: These 2 Stocks Will Outperform the Mar... Source: Prosper Junior Bakiny Financials   TTM Q1 2025 Q4 2024 Basic EPS $-5.77 $-1.22 $-1.54 Diluted EPS $-5.77 $-1.22 $-1.54 Revenue $ 432.16M $ 121.46M $ 118.77M Gross Profit $ $ $ Net Income / Loss $ -278.27M $ -59.41M $ -74.91M Operating Income / Loss $ -270.27M $ -56.98M $ -72.62M Cost of Revenue $ $ $ Net Cash Flow $ -30.53M $ -14.44M $ -11.99M PE Ratio